Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences
Dr. Flühmann is a Pharmacist by training and holds a PhD in molecular biology from ETH Zürich, Switzerland on “Structural analysis and characterization of cell surface receptors” and a MBA of the University of St. Gallen Switzerland. He was working in various position in the field of pharmaceuticals and functional nutrition. Dr. Flühmann was leading a global multidisciplinary research and development team at Roche/DSM nutritional products developing novel compounds for the prevention and treatment of diabetes. At Vifor Pharma Ltd Dr. Flühmann was acting as Global Brand Director defining global strategic product plans across all functions (medical, marketing, market research, regulatory, life cycle management, logistics) and ensuring the operational execution. In his current position at Vifor Pharma Ltd Dr. Flühmann is Global Lead Non-Biological Complex Drugs with a main interest in regulatory aspects of nanomedicines. He is Steering Committee Member of the Non-Biological Complex Drugs Working Group hosted at Lygature a non for profit organization. The mission of the Non-Biological Complex Drugs Working Group is to work on appropriate and harmonized science-based approval and post-approval standards for Non-Biological Complex Drugs to ensure patient benefit and safety.
Regulatory aspects of nanomedicines, Non-Biological Complex Drugs, medical, marketing, market research, regulatory, life cycle management, logistics